Case study – Botswana: Launches Med Safety App and e-reporting

Communications / 17 March 2020

Minister of Health and Wellness Dr Lemogang Kwape launches the Med Safety App in Botswana. Photo: BoMRA

The Botswana Medicines Regulatory Authority (BoMRA) started operation in 2018 and intends to be fully operational in 2020, reaching WHO maturity level 3 by 2023. As it works to achieve those goals, BoMRA recently took an important step towards securing two essential elements of a robust national pharmacovigilance programme – active stakeholder participation and a strong culture of reporting.

On 14 November 2019, BoMRA launched the Med Safety App at an event attended by 140 delegates, including 125 healthcare professionals. Among the featured guests were the Honourable Minister of Health and Wellness, Dr Lemogang Kwape; CEO of BoMRA, Dr Stephen Ghanie; WHO representative, Ayako Fukushima; and the WHO local office representative, Kefentse Moakofi.

In his keynote address, the minister expressed the seriousness with which his ministry views medication errors and the harmful effects of medicines. He noted the recognised problem of ADR underreporting and commended BoMRA’s initiative in launching e-reporting to help healthcare professionals improve their reporting levels.

Following a remote presentation of e-reporting by UMC and expressions of support from MHRA and WHO, it was time for the official unveiling of the Med Safety App and e-reporting – flashing lights and a loud-bang signalling a new dawn on ADR reporting in Botswana.

With multiple stations set up to demonstrate the Med Safety App and e-reporting tools, the attendees got the opportunity to practise reporting using the platforms and ask questions. The response from participants was positive, and BoMRA was lauded for helping to reduce the time spent on paper-based reporting.

Since the launch, BoMRA has continued to build awareness and has extended training to 196 healthcare professionals across the country on pharmacovigilance and reporting platforms. By the start of February 2020, BoMRA had received 12 ADR reports – five from physicians and seven from pharmacists – via the Med Safety app.

Bomra CEO Dr Stephen Ghanie Giving Welcome Remarks
<div class='columns imageGallary'>
Bomra Poster 2 (1)
Bomra Car
Pharmacovigilance Team
</div><div class='columns imageGallary'>
Bomra Launch
</div>
Tags: MedSafetyApp, Africa, Botswana, mobile, e-reporting

Parthasarathi Gurumurthy
Director, Post Marketing Surveillance and Control of Clinical Trials, Botswana Medicines Regulatory Authority

You may also like


New podcast drops – How do we change behaviour around antimicrobial resistance?

Antimicrobial resistance threatens one of the key pillars of modern medicine. The latest episode of Drug Safety Matters asks how we got here – and how we get out.

Communications / 27 April 2021

Good news – The newsletter is back

Email newsletter are back in style. And for health communicators in a time of pandemic, one could argue that they have have never been more useful.

Communications / 29 March 2021

New podcast episode – Into the infodemic

Tune in to the latest in our Drug Safety Matters Long Reads series, exploring how pharmacovigilance experts can help win the war on viral misinformation – by not fighting it.

Communications / 29 March 2021

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more